🍼 Japan had 686,173 babies in 2024, the fewest since records began. Of those, 86,473 started in a laboratory dish. That is roughly one child in eight, also a record. And in the same year, clinics performed fewer treatments than the year before.

The year one in eight became normal

The Japan Society of Obstetrics and Gynecology released its 2024 assisted reproduction figures on September 3, 2026: 86,473 children born through in vitro fertilization and related techniques, up 1,436 from the previous year and the highest the society has ever recorded.

Set that against the Ministry of Health, Labour and Welfare's confirmed count of 686,173 births in 2024, and the arithmetic gives you about one baby in eight. Japan's total fertility rate that year was 1.15, the lowest ever measured, and births fell by 41,115 in twelve months.

So the ratio is climbing from both directions. More children are being conceived in clinics, and fewer are being conceived any other way. Japan's first IVF baby was born at Tohoku University in 1983, and counting from 1985, when the society began keeping statistics, the running total passed one million in 2023.

Fewer treatments, more babies

Clinics logged 550,265 treatments in 2024. The year before, the figure was 561,664. Treatment volume went down while births went up.

There are a few plausible readings, and the society has not settled on one. Freezing techniques have improved to the point where the overwhelming majority of IVF babies in Japan now come from thawed embryos rather than fresh transfers, so a single egg retrieval can produce several chances at pregnancy across later cycles. It is also possible that the surge of patients who arrived when insurance coverage began in 2022 has worked its way through the system, leaving a smaller but steadier caseload.

What the twin rate is telling us

The multiple-birth rate for IVF pregnancies reached 4.15 percent in 2024, roughly 1.3 times the 2022 level.

For most of the past two decades Japan pushed in the opposite direction. The professional guidance is to transfer a single embryo as a rule, with two permitted only for women aged 35 and over or after two cycles that failed to produce a pregnancy. Twin and triplet pregnancies carry far higher risks of premature delivery, low birth weight and complications for the mother, and they occupy scarce neonatal intensive care beds. Driving the multiple rate down was treated as a mark of a mature ART programme.

Yukiko Katagiri, the Toho University professor of reproductive medicine who chairs the society's registration and research subcommittee, offered an explanation that points straight at policy design. Insurance-covered treatment comes with a hard cap on attempts, she said, so more patients are choosing to put back two embryos at once in the hope of converting a limited allowance into a pregnancy.

That is a rational response to a rule. Coverage made treatment affordable, and the cap on attempts appears to be nudging some patients toward a riskier version of it.

What Japan's 2022 reform changed, and what it left alone

Before April 2022, IVF in Japan sat outside the national health insurance system. Patients paid the full price and applied for a subsidy of ¥300,000 (about $1,900) per cycle, which rarely covered everything.

Since then the basic treatments have been folded into public insurance, so patients pay the standard 30 percent share and can claim the high-cost medical expense benefit on top. As of September 2026 the conditions are unchanged: treatment must begin before the woman turns 43, and coverage runs to six embryo transfers for patients under 40 and three for those aged 40 to under 43. One more requirement surprises readers abroad. The couple must be legally married or in a documented common-law partnership, which leaves single women and same-sex couples outside the scheme.

The financial barrier came down sharply. The eligibility gates stayed where they were.

Denmark, Israel, Australia: three other answers

Denmark leans on the same technology harder than Japan does. In 2025, 8,782 Danish children were born after fertility treatment out of 59,443 births, or 14.8 percent, according to the Danish Health Data Authority. That is better than one in seven, though the comparison is not exact: the Danish count includes intrauterine insemination, while Japan's 86,473 covers IVF-type treatment only. Public funding explains much of the gap. Denmark doubled its publicly funded attempts from three to six in 2024, extended free treatment to a second child that December with 150 million kroner (about $23 million) a year set aside, and raised the second-child allowance to six attempts from January 2026. Referral to a public clinic must happen before a woman turns 40; private clinics treat until 46. Single women qualify on the same terms as couples. With a fertility rate near 1.5, Denmark discusses all of this openly as demographic strategy rather than only as healthcare.

Israel runs one of the most generous systems anywhere. Its national health insurance funds an unlimited number of cycles until a woman has two children with her current partner, up to age 45, regardless of marital status or sexual orientation. Israelis use fertility treatment at the highest per-capita rate in the world. The model has critics at home: the State Comptroller's 2024 audit found treatment migrating from public hospitals to private units, and clinicians have long argued that unlimited access can keep patients in treatment past the point where the odds justify it.

Australia sits in the middle. Medicare rebates apply with no cap on cycles and no age limit, and in 2025 the eligibility rules were rewritten to remove restrictions based on relationship status, sexual orientation or gender identity. But the rebate covers a portion, not the bill. Australian clinics generally put out-of-pocket costs between A$4,500 and A$6,500 per full cycle, or roughly $3,200 to $4,700. About one in eighteen Australian babies is born through ART, rising to one in ten for mothers aged 35 and over, according to the national registry.

Denmark buys attempts. Israel removes the ceiling. Australia keeps the door open to everyone and lets cost do the filtering. Japan has chosen cheap treatment with a fixed number of tries and a defined list of who qualifies.

What the numbers leave out

A record year for IVF births is not really a story about technology. The technology has been working for forty years. What changed is how many people need it, and how late they reach it.

Japan's treatment volume is concentrated among women around 40, and the 43-year ceiling sits there because success rates fall away steeply past it. The six-attempt allowance traces the same reality. Japan already leans on this technology heavily: a 2023 analysis in Fertility and Sterility Reports put it second among the countries it compared for IVF cycles per million people in 2018, behind Israel and just ahead of Denmark. Whether cheap but time-limited is the right answer for a country losing 41,115 births a year is not something the data can settle.

How far does public insurance go for fertility treatment where you live, and who does it leave out?

References